Key | % Net Assets |
---|---|
Altria | 3.0% |
Pfizer | 3.0% |
Royal Dutch Shell | 2.8% |
Bristol-Myers Squibb | 2.7% |
Other | 88.5% |
Name | % Net Assets |
---|---|
Altria | 3.0% |
Pfizer | 3.0% |
Royal Dutch Shell | 2.8% |
Bristol-Myers Squibb | 2.7% |
McDonalds | 2.6% |
Coca-Cola | 2.5% |
Merck & Co | 2.5% |
Muenchener Rueckversicherungs | 2.5% |
Unilever | 2.4% |
Koninklijke | 2.3% |
No asset data available.
Date | 09-Sep-2022 |
---|---|
NAV | 120.80p |
Currency | GBP |
Change | 1.20p |
% | 1.00% |
YTD change | 120.80p |
YTD % | n/a |
Fund Inception | 07/02/2007 |
---|---|
Fund Manager | n/a |
TER | 1.68 (31-Jan-2013) |
Minimum Investment | |
---|---|
Initial | £1000 |
Additional | £100 |
Savings | n/a |
Charges | |
---|---|
Initial | 4.25% |
Annual Mang't | 1.50% |
Exit | n/a |
Name | % |
---|---|
No risk data available. |
You are here: research